Literature DB >> 19880104

Arsenic in public water supplies and cardiovascular mortality in Spain.

M A José Medrano1, Raquel Boix, Roberto Pastor-Barriuso, Margarita Palau, Javier Damián, Rebeca Ramis, José Luis Del Barrio, Ana Navas-Acien.   

Abstract

BACKGROUND: High-chronic arsenic exposure in drinking water is associated with increased cardiovascular disease risk. At low-chronic levels, as those present in Spain, evidence is scarce. In this ecological study, we evaluated the association of municipal drinking water arsenic concentrations during the period 1998-2002 with cardiovascular mortality in the population of Spain.
METHODS: Arsenic concentrations in drinking water were available for 1721 municipalities, covering 24.8 million people. Standardized mortality ratios (SMRs) for cardiovascular (361,750 deaths), coronary (113,000 deaths), and cerebrovascular (103,590 deaths) disease were analyzed for the period 1999-2003. Two-level hierarchical Poisson models were used to evaluate the association of municipal drinking water arsenic concentrations with mortality adjusting for social determinants, cardiovascular risk factors, diet, and water characteristics at municipal or provincial level in 651 municipalities (200,376 cardiovascular deaths) with complete covariate information.
RESULTS: Mean municipal drinking water arsenic concentrations ranged from <1 to 118 microg/L. Compared to the overall Spanish population, sex- and age-adjusted mortality rates for cardiovascular (SMR 1.10), coronary (SMR 1.18), and cerebrovascular (SMR 1.04) disease were increased in municipalities with arsenic concentrations in drinking water > 10 microg/L. Compared to municipalities with arsenic concentrations < 1 microg/L, fully adjusted cardiovascular mortality rates were increased by 2.2% (-0.9% to 5.5%) and 2.6% (-2.0% to 7.5%) in municipalities with arsenic concentrations between 1-10 and >10 microg/L, respectively (P-value for trend 0.032). The corresponding figures were 5.2% (0.8% to 9.8%) and 1.5% (-4.5% to 7.9%) for coronary heart disease mortality, and 0.3% (-4.1% to 4.9%) and 1.7% (-4.9% to 8.8%) for cerebrovascular disease mortality.
CONCLUSIONS: In this ecological study, elevated low-to-moderate arsenic concentrations in drinking water were associated with increased cardiovascular mortality at the municipal level. Prospective cohort studies with individual measures of arsenic exposure, standardized cardiovascular outcomes, and adequate adjustment for confounders are needed to confirm these ecological findings. Our study, however, reinforces the need to implement arsenic remediation treatments in water supply systems above the World Health Organization safety standard of 10 microg/L. 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19880104     DOI: 10.1016/j.envres.2009.10.002

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  47 in total

1.  Concentrations of urinary arsenic species in relation to rice and seafood consumption among children living in Spain.

Authors:  Antonio J Signes-Pastor; Jesus Vioque; Eva M Navarrete-Muñoz; Manus Carey; Manoli García de la Hera; Jordi Sunyer; Maribel Casas; Isolina Riaño-Galán; Adonina Tardón; Sabrina Llop; Rubén Amorós; Pilar Amiano; José R Bilbao; Margaret R Karagas; Andrew A Meharg
Journal:  Environ Res       Date:  2017-08-01       Impact factor: 6.498

2.  Exposure to moderate arsenic concentrations increases atherosclerosis in ApoE-/- mouse model.

Authors:  Maryse Lemaire; Catherine A Lemarié; Manuel Flores Molina; Ernesto L Schiffrin; Stéphanie Lehoux; Koren K Mann
Journal:  Toxicol Sci       Date:  2011-04-21       Impact factor: 4.849

3.  Towns with extremely low mortality due to ischemic heart disease in Spain.

Authors:  María José Medrano; Raquel Boix; Alba Palmera; Rebeca Ramis; Iñaki Galán; Gonzalo López-Abente
Journal:  BMC Public Health       Date:  2012-03-09       Impact factor: 3.295

4.  Association between arsenic exposure from drinking water and plasma levels of cardiovascular markers.

Authors:  Fen Wu; Farzana Jasmine; Muhammad G Kibriya; Mengling Liu; Oktawia Wójcik; Faruque Parvez; Ronald Rahaman; Shantanu Roy; Rachelle Paul-Brutus; Stephanie Segers; Vesna Slavkovich; Tariqul Islam; Diane Levy; Jacob L Mey; Alexander van Geen; Joseph H Graziano; Habibul Ahsan; Yu Chen
Journal:  Am J Epidemiol       Date:  2012-04-24       Impact factor: 4.897

5.  Risk of death from cardiovascular disease associated with low-level arsenic exposure among long-term smokers in a US population-based study.

Authors:  Shohreh F Farzan; Yu Chen; Judy R Rees; M Scot Zens; Margaret R Karagas
Journal:  Toxicol Appl Pharmacol       Date:  2015-06-03       Impact factor: 4.219

6.  Low-level inorganic arsenic exposure and neuropsychological functioning in American Indian elders.

Authors:  Clint R Carroll; Carolyn Noonan; Eva M Garroutte; Ana Navas-Acien; Steven P Verney; Dedra Buchwald
Journal:  Environ Res       Date:  2017-05-12       Impact factor: 6.498

7.  Sodium arsenite represses the expression of myogenin in C2C12 mouse myoblast cells through histone modifications and altered expression of Ezh2, Glp, and Igf-1.

Authors:  Gia-Ming Hong; Lisa J Bain
Journal:  Toxicol Appl Pharmacol       Date:  2012-03-09       Impact factor: 4.219

8.  Arsenic exposure and cancer mortality in a US-based prospective cohort: the strong heart study.

Authors:  Esther García-Esquinas; Marina Pollán; Jason G Umans; Kevin A Francesconi; Walter Goessler; Eliseo Guallar; Barbara Howard; John Farley; Lyle G Best; Ana Navas-Acien
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-10-17       Impact factor: 4.254

9.  Standards for arsenic in drinking water: Implications for policy in Mexico.

Authors:  Andrew T Fisher; Lizbeth López-Carrillo; Brenda Gamboa-Loira; Mariano E Cebrián
Journal:  J Public Health Policy       Date:  2017-11       Impact factor: 2.222

10.  Arsenic Exposure in Relation to Ischemic Stroke: The Reasons for Geographic and Racial Differences in Stroke Study.

Authors:  Cari L Tsinovoi; Pengcheng Xun; Leslie A McClure; Vivian M O Carioni; John D Brockman; Jianwen Cai; Eliseo Guallar; Mary Cushman; Frederick W Unverzagt; Virginia J Howard; Ka He
Journal:  Stroke       Date:  2017-12-06       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.